Home > Resources > Whitepapers > How to improve manufacturing process efficiency to increase speed-to-market

Research, PHARMA TECH

How to improve manufacturing process efficiency to increase speed-to-market

November 18, 2022

How to improve manufacturing
Research by McKinsey on the operational practices of more than 25 global pharmaceutical manufacturers found that the top companies are more than twice as productive as their counterparts. 

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Medicines Forum Africa

Medicines Forum Africa is an open platform for exchange of views between policymakers and stakeholders that aims to enhance public private collaboration in the pharmaceuticals policy-shaping process and making sure that new policies related to access to medicines are goal-oriented, operational and comprehensive. The Forum operates on not-for-profit principles and is incorporated in the United Kingdom as a company limited by guarantee (ie does not have any shares or shareholders), and its surpluses are principally applied toward the promotion of the objects of the Forum.

OTHER WHITEPAPERS
news image

Blockchain technology in the pharmaceutical industry

whitePaper | March 11, 2022

Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry.

Read More
news image

PHARMACEUTICAL KEY ACCOUNT MANAGEMENT: HARNESSING SALES EXPERTISE TO DEVELOP UNIFIED STAKEHOLDER RELATIONSHIPS

whitePaper | November 25, 2022

To meet the needs of a growing range of external stakeholders, many life science companies are changing the ways that they disseminate information.

Read More
news image

A Comparison of Substance Use Disorders before and during theCOVID-19 Pandemic

whitePaper | September 22, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

Read More
news image

Patients Diagnosed with Post-COVID Conditions

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern.

Read More
news image

Advancements in Drug Development and Formulation

whitePaper | December 13, 2022

A recent e-symposium presented insights into the latest research and innovative solutions to help shorten timeto-market, reduce development costs, increase yield, and assure quality and pharmacopoeia compliance throughout the drug development process.

Read More
news image

Strengthening Engagement and Influence with Key Decision Makers

whitePaper | January 5, 2023

This report follows up on the jointly hosted Pharmaforce and elandas webinar which took place on July, 12, 2016, featuring contributions from participating industry leaders who formed the expert panel, as well as the live contributions of the audience of healthcare sales and marketing professionals.

Read More

Blockchain technology in the pharmaceutical industry

whitePaper | March 11, 2022

Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry.

Read More

PHARMACEUTICAL KEY ACCOUNT MANAGEMENT: HARNESSING SALES EXPERTISE TO DEVELOP UNIFIED STAKEHOLDER RELATIONSHIPS

whitePaper | November 25, 2022

To meet the needs of a growing range of external stakeholders, many life science companies are changing the ways that they disseminate information.

Read More

A Comparison of Substance Use Disorders before and during theCOVID-19 Pandemic

whitePaper | September 22, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

Read More

Patients Diagnosed with Post-COVID Conditions

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern.

Read More

Advancements in Drug Development and Formulation

whitePaper | December 13, 2022

A recent e-symposium presented insights into the latest
research and innovative solutions to help shorten timeto-market, reduce development costs, increase yield,
and assure quality and pharmacopoeia compliance
throughout the drug development process.

Read More

Strengthening Engagement and Influence with Key Decision Makers

whitePaper | January 5, 2023

This report follows up on the jointly hosted Pharmaforce
and elandas webinar which took place on July, 12,
2016, featuring contributions from participating industry
leaders who formed the expert panel, as well as the live
contributions of the audience of healthcare sales and
marketing professionals.

Read More
More Whitepapers

Spotlight

Medicines Forum Africa

Medicines Forum Africa is an open platform for exchange of views between policymakers and stakeholders that aims to enhance public private collaboration in the pharmaceuticals policy-shaping process and making sure that new policies related to access to medicines are goal-oriented, operational and comprehensive. The Forum operates on not-for-profit principles and is incorporated in the United Kingdom as a company limited by guarantee (ie does not have any shares or shareholders), and its surpluses are principally applied toward the promotion of the objects of the Forum.

Events